Didi, China's biggest ride-hailing company, has achieved a $67.5 billion valuation ahead of its expected debut on the New York Stock exchange on Wednesday. The company raised $4.4 billion after ...

However, the listing approval procedures for a listing by introduction are the same as those for an IPO, meaning Didi still would face regulatory scrutiny from the Stock Exchange of Hong Kong over its ...

China watchdog casts its gaze on Didi, sending stock tumbling days after IPO The news furthers China's effort to corral its largest tech companies. China’s ride-hailing giant Didi could be the ...

With the first $1-billion-plus IPO in New York by a Chinese-owned company post-Didi safely in the books ... as appealing as a spot on the New York Stock Exchange or Nasdaq. Hong Kong would make ...

DiDi's ADRs plummeted 18% to $2.01 after convening an extraordinary general meeting on May 23 to vote on the exclusion of its shares from the New York Stock Exchange ... after its IPO and forced ...

and Didi Global Inc. A boom in India’s IPO market is buoying the Vision Fund ... ability to meaningfully improve people’s ...

Short interest in DiDi Global Inc (OTC:DIDIY) increased during the last reporting period, rising from 1.45M to 3.74M. This put 0.13% of the company's publicly available shares short. Short ...

In response to Didi and other big tech firms listing abroad ... These new restrictions come on top of China’s long-standing limits on domestic IPOs. The overall effect of these policies ...

More bad news for Didi as the stock continued its decline in premarket ... Cramer called Didi the final straw in the complicated story of the Chinese IPO. "We have been patsies for too long.

Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering, becoming the first sizeable Chinese firm to pursue a listing in the U.S. this year.